Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

“Hard” Drug Repurposing for Precision Oncology: The Missing Link? | Synapse

June 14, 2018Open Access

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?

PPPan PantziarkaAnticancer Fund GBGauthier BoucheMRC Clinical Trials Unit at UCL NANicolás AndréBen-Gurion University of the Negev

Key Points

Key points are not available for this paper at this time.

Abstract

OPINION article Front. Pharmacol., 14 June 2018Sec. Cancer Molecular Targets and Therapeutics Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.00637

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Pantziarka et al. (Thu,) studied this question.

synapsesocial.com/papers/69d9d9a85e5bcb4e3b838069 https://doi.org/https://doi.org/10.3389/fphar.2018.00637